主要胆道胆道炎的不断变化的治疗景观:一篇综述
Natalie E Mitchell1, Shu-Yen Chan2, David Jerez Diaz3
1Department of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester, NY 14682, United States.
World journal of hepatology
|August 1, 2025
概括
主要胆道胆炎 (PBC) 的治疗方法正在发展,超出了ursodeoxycholic acid (UDCA) 的范围. 新疗法针对不充分的反应和耐火性疾病,为肝脏患者提供更好的结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 自免疫性疾病 自免疫性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 初级胆道胆炎 (PBC) 是一种慢性自身免疫性肝病,导致胆道破坏,纤维化和潜在的肝衰竭.
- Ursodeoxycholic acid (UDCA) 是标准的治疗方法,但40%的患者表现出不充分的反应.
- 这凸显了在耐火性PBC病例中对有效疗法的重大未满足需求.
研究的目的:
- 审查一次性胆道胆道炎 (PBC) 治疗策略的演变.
- 讨论新兴的治疗方法,以解决对当前疗法反应不足的患者未得到满足的需求.
- 探索新型药物和个性化医学的潜力,以改变PBC管理.
主要方法:
- 在过去二十年中,对初级胆汁胆道炎 (PBC) 治疗的进展进行文献综述.
- 分析已经确立的治疗方法,如ursodeoxycholic 酸 (UDCA) 和二线药物,如obeticholic 酸 (OCA).
- 检查正在进行的关于新型药物类别的研究,包括纤维酸,PPAR激动剂,免疫调节剂,胆酸运输抑制剂,抗纤维菌剂和微生物组向疗法.
主要成果:
- 乌尔索多西胆酸 (UDCA) 改善了结果,但在很大一部分患者中是无效的.
- 肥酸 (OCA) 证明了作为二线治疗的有效性,改善了肝脏的生物化学.
- 一系列新型药物正在开发中,针对自身免疫性损伤,纤维化和肠道微生物组的改变.
结论:
- 初级胆管胆道炎 (PBC) 的治疗场景正在迅速扩大到UDCA之外.
- 新兴疗法为耐火性疾病和未满足需求的患者提供了重大前景.
- 预计整合新药的精准医学方法将彻底改变PBC患者的治疗结果.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:24Chronic Pancreatitis I: Introduction
162
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
162
01:17Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
01:30Acute Pancreatitis II: Clinical Manifestations and Management
177
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
177